Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652923 | SCV000774795 | benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000652923 | SCV000897311 | uncertain significance | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2021-12-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002282293 | SCV002571211 | uncertain significance | not provided | 2024-06-03 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function |
Genome |
RCV000652923 | SCV004228711 | not provided | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 04-23-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |